John Siemon, MD
“What truly sets Gynecologic Oncology apart from other specialties, is the comprehensive care we provide for our patients. It is the only specialty where the physician performing the surgery is also the physician providing the short and long-term medical management. This allows us to build strong relationships with our patients over time and optimize patient outcomes based on our unique understanding of how the gynecologic disease process and treatment options affect all aspects of our patient’s health and wellbeing.“
Dr. John Siemon is a Board-Eligible Gynecologic Oncologist. He earned his medical degree from Drexel University College of Medicine. He also completed his residency in Obstetrics and Gynecology and his fellowship in Gynecologic Oncology at The University of Miami, Jackson Memorial Hospital, and Sylvester Comprehensive Cancer Center.
Dr. Siemon is expertly trained to perform both laparoscopic and robotic advanced pelvic surgery for benign gynecologic conditions, such as fibroids, endometriosis, ovarian cysts, vaginal bleeding, vaginal/vulvar conditions, and pelvic pain. He has extensive experience in the surgical management of early and advanced gynecologic malignancies and is a leader in the field of rare ovarian malignancies. Dr. Siemon is also well-versed in leading-edge cancer therapies, including chemotherapy, immunotherapy, targeted therapy, and precision and personalized cancer medicine.
Dr. Siemon’s patients describe him as professional, kind, caring, honest, and extremely patient. They love his way of explaining their diagnosis and management plan in a way they can understand, empowering them to take an active role in their healthcare decision-making process.
As a dedicated researcher, Dr. Siemon has authored or co-authored more than 30 publications and conference proceedings, and won a number of awards for his research. He has participated in numerous research projects over the years; but his passion has remained in the area of rare ovarian malignancies, for which he is a leader in the field. Dr. Siemon was actively involved in the first-ever low-grade serous ovarian carcinoma symposium, during which renowned experts from around the world met to collaborate and develop formal guidelines and recommendations to aid physicians across the country in managing these rare and often difficult conditions. He is also deeply invested in resident and fellow education and enjoys training the next generation of Gynecologists.
